The Business of Drugs · S1 · E2
Synthetics
Despite its potential therapeutic benefits, MDMA is pushed into the shadows where it — along with synthetic analogs — have become popular party drugs.
About this episode
Despite its potential therapeutic benefits, MDMA is pushed into the shadows where it — along with synthetic analogs — have become popular party drugs.
Season 1
1Cocaine
46 minJul 14, 2020
From farming to smuggling to sales, former CIA analyst Amaryllis Fox investigates cocaine's hugely profitable and disturbingly deadly business cycle.
2Synthetics
39 minJul 14, 2020Now viewing
Despite its potential therapeutic benefits, MDMA is pushed into the shadows where it — along with synthetic analogs — have become popular party drugs.
3Heroin
40 minJul 14, 2020
Fox travels to Kenya, where she speaks to people living and working on the front lines of one of the world's newest and most profitable heroin routes.
4Meth
47 minJul 14, 2020
Meth's global menace infects Myanmar, where complex politics and history have made it Southeast Asia's ground zero for production and distribution.
5Cannabis
44 minJul 14, 2020
Despite the legalization of pot in California, roughly 80% of the state's cannabis sales still occur on the black market. Fox examines why.
6Opioids
40 minJul 14, 2020
Fox explores how highly addictive oxycodone continues to cause unprecedented destruction across America and even pushes addicts toward heroin.
Guest stars
